TPK1
protein-codingthiamin pyrophosphokinase 1
Gene summary
The protein encoded by this gene functions as a homodimer and catalyzes the conversion of thiamine to thiamine pyrophosphate, a cofactor for some enzymes of the glycolytic and energy production pathways. Defects in this gene are a cause of thiamine metabolism dysfunction syndrome-5. [provided by RefSeq, Apr 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~384.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013761
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between TPK1 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of August 10, 2020. The TPK1 gene encodes thiamine pyrophosphokinase 1, which catalyzes the conversion of thiamine to thiamine pyrophosphate (thiamine diphosphate or TDP). TDP is the metabolically active form of thiamine, which acts a cofactor of several thiamine-dependent enzymes in the cytosol, peroxisomes, and mitochondria. In the mitochondria, TDP acts as a cofactor of the pyruvate dehydrogenase complex. The TPK1 gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2011 (PMID: 22152682). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 10 variants identified in seven cases in six publications (PMIDs: 22152682, 25458521, 27896076, 30483896, 30789823, 31288420). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by biochemical function, expression data, and model systems (PMIDs: 31095747, 18853439, 31127358). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on August 10, 2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0013761
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013761
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013761
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: Biochemical
Rationale: In some individuals, thiamine supplementation appears to have beneficial effect (related compounds may be beneficial as well)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TPK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022445.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 55 | 56 | |||
| missense | 3 | 9 | 106 | 2 | 120 | |
| nonsense | 2 | 1 | 3 | |||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 2 | 7 | |||
| splice donor/acceptor (+/-2bp) | 3 | 6 | 1 | 10 | ||
| Total | 14 | 18 | 108 | 57 | 0 | 197 |
Highest pathogenic variant AF is 0.00010227788
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071890.2 | 8 | MANE Select | |
| Ensembl | ENSP00000353165.3 | 8 | MANE Select | |
| RefSeq | NP_001035947.1 | 7 | Standard | |
| RefSeq | NP_001337808.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thiamine metabolism - Homo sapiens (human)
- Thiamine Metabolism
- thiamin salvage III
- Vitamin B1 (thiamin) metabolism
- Metabolism
Biological Process
- thiamine metabolic process
- thiamine diphosphate biosynthetic process
- phosphorylation
- thiamine-containing compound metabolic process
Molecular Function
- thiamine diphosphokinase activity
- ATP binding
- kinase activity
- thiamine binding
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000360057
- Coding exons
- 8
- Length
- 384455
- Individuals with no LoFs
- 125733
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 14
- Defined
- 125747
- p
- 0.0000557
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.342 | 121 | 132 | 0.916 | 0.00000655 | 1594 |
| Missense (PolyPhen) | 47 | 51.835 | 0.90672 | 613 | ||
| Synonymous | 0.340 | 44 | 47.0 | 0.937 | 0.00000250 | 446 |
| Loss of Function | 2.33 | 4 | 13.1 | 0.306 | 5.50e-7 | 167 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.000067 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of thiamine to thiamine pyrophosphate. Can also catalyze the phosphorylation of pyrithiamine to pyrithiamine pyrophosphate. {ECO:0000269|PubMed:11342111}.;
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- LoFtool
- 0.322
- RVIS EVS
- 0.06
- RVIS percentile EVS
- 58.26
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.916
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |